{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"condition":["Advanced Colorectal Cancer"],"disease":["Advanced Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2692583"],"location":["China"],"study_start_month":["4"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Phase II Clinical Trial for PD-1 inhibitor with Metronomic chemotherapy for Advanced Colorectal Cancer with microsatellite stability (MSS)","description":"Interventions: Case series:fPD-1 inhibitor with Metronomic chemotherapy\nPrimary outcome(s): Overall survival, OS;Progression-free survival, PFS\nStudy Design: Single arm","dates":{"creation":"2020-04-15"},"accession":"2692583","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2000032079"]}}